rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Elisabeth Leiderman

Director

Company insider

Files Form 4 as: Director, Autolus Therapeutics; Director, bluebird bio; Chief Financial Officer, Decibel Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
18
Buys
0
Sells
1
Bought
$0
Sold
$6,486
Companies
3
Companies where not an officer
2
First trade
15 Oct 2021
Last trade
29 Jun 2026
Last filed
1 Jul 2026

Companies traded

Where they are an officer
Decibel TherapeuticsOfficer · last 25 Feb 20220 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
AUTL Autolus TherapeuticsDirector · Biotechnology · last 29 Jun 20260 buys · 0 sells
bluebird bioDirector · last 2 Jun 20250 buys · 1 sell

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
29 Jun 2026filed 1 Jul 2026AUTL Autolus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,667 at $0.00filing
29 Jun 2026filed 1 Jul 2026AUTL Autolus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—47,500 at $0.00filing
29 Jun 2026filed 1 Jul 2026AUTL Autolus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,667 at $0.00filing
29 Jun 2026filed 1 Jul 2026AUTL Autolus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—47,500 at $0.00filing
2 Jun 2025filed 3 Jun 2025bluebird bioSEC FORM 4 Code D—1,245filing
30 May 2025filed 3 Jun 2025bluebird bioSEC FORM 4 Code U—1,112filing
6 Nov 2024filed 8 Nov 2024bluebird biooption or derivativeSEC FORM 4 Code A—49,850 at $0.00filing
6 Nov 2024filed 8 Nov 2024bluebird bioSEC FORM 4 Code A—24,900 at $0.00filing
16 Jun 2023filed 20 Jun 2023bluebird biooption or derivativeSEC FORM 4 Code A—21,600 at $0.00filing
16 Jun 2023filed 20 Jun 2023bluebird bioSEC FORM 4 Code A—10,790 at $0.00filing
17 Oct 2022filed 9 Mar 2023bluebird bioSEC FORM 4 Sold$6,4861,004 at $6.46filing
22 Jun 2022filed 23 Jun 2022bluebird biooption or derivativeSEC FORM 4 Code A—5,000 at $0.00filing
22 Jun 2022filed 23 Jun 2022bluebird bioSEC FORM 4 Code A—3,109 at $0.00filing
25 Feb 2022filed 28 Feb 2022Decibel Therapeuticsoption or derivativeSEC FORM 4 Code A—52,500 at $0.00filing
11 Nov 2021filed 16 Nov 2021bluebird biooption or derivativeSEC FORM 4 Code D—15,057 at $0.00filing
11 Nov 2021filed 16 Nov 2021bluebird bioSEC FORM 4 Code J—9,361 at $0.00filing
15 Oct 2021filed 19 Oct 2021bluebird biooption or derivativeSEC FORM 4 Code A—7,500 at $0.00filing
15 Oct 2021filed 19 Oct 2021bluebird bioSEC FORM 4 Code A—4,663 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.